All In MedTech

FDA Clearance Tracker · P210032-S019

GORE TAG Thoracic Branch Endoprosthesis (TBE Device)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 21, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 21, 2025

Approved

Time to decision

104 days

Received May 9, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P210032-S019
Device name
GORE TAG Thoracic Branch Endoprosthesis (TBE Device)
Applicant location
Flagstaff, AZ
Received
May 9, 2025
Decided
Aug 21, 2025
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P210032

Device type

Device class
Class III

Every decision under product code MIH

FDA's approval statement

As written in FDA's record.

approval of the protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P210032/S015.

Source documents

Other decisions for W. L. Gore & Associates, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.